Search News
Search
Close this search box.

Neuland Lab tanks 5% as USFDA issues observations to Hyderabad facility – Economic Times

© Provided by The Rahnuma Daily


Economic Times

Neuland Lab tanks 5% as USFDA issues observations to Hyderabad facility
Economic Times
NEW DELHI: Shares of Neuland Laboratories tanked over 5 per cent in Monday’s trade after the drugmaker that the USFDA has issued two observations, under form 483, to its manufacturing facility (unit 1) at Bonthapally, Hyderabad after inspecting it
Neuland Labs gets 2 USFDA observations for Hyderabad facilityHindu Business Line

all 5 news articles »

share it
Facebook
Twitter
LinkedIn
WhatsApp

Get free tips and resources right in your inbox, along with 10,000+ others

Related Article